Assessment of Usefulness of CRP, PMN Elastase, PCT and Il- 6 as Prognostic Factors in Patients with Acute Pancreatitis

Acute Pancreatitis and Markers

  • B. Jagan Mohan Reddy Assistant Professor, Department of Surgical Gastroenterology, Sapthagiri Institute of Medical Sciences and Research Centre, Bangalore, Karnataka, India
  • S.P. Girish Associate Professor, Department of Surgical Gastroenterology, Sapthagiri Institute of Medical Sciences and Research Centre, Bangalore, Karnataka, India
Keywords: Acute Pancreatitis, PMN-Elastase, Markers

Abstract

Background: Acute pancreatitis is an inflammatory disease of the exocrine pancreas with rapid onset. The present study was conducted to assess the usefulness of CRP, PMN elastase, PCT and IL- 6 as prognostic factors in patients with acute pancreatitis. Subjects and Methods: The present study comprised 53 patients who presented with a diagnosis of Acute Pancreatitis. CRP was estimated by turbidimetric immunoassay using CRP/U2A-000 kit. PMN-Elastase was estimated by solid-phase enzyme immunoassay. Procalcitonin was estimated by the immuno- chromatographic test. IL-6 was estimated by Immuno-enzymatic assay. Results: There were 47 males and 6 females in the present study. The mean SD CRP in patients with mild pancreatitis was 44.35 53.04 and in severe pancreatitis was 174.80 14.55, PCT was seen in 4 in mild pancreatitis patients and 12 in severe pancreatitis patients, PMN- elastase level was 3.89 1087 in mild pancreatitis and 3.99 2.75 inn severe pancreatitis patients, IL-6 level was 129.63 319.08 in mild pancreatitis and 1166.76 818.06 in severe pancreatitis patients. The difference was significant (P< 0.05). CRP had higher (100) specificity as compared to PCT (81), PMN- E (10) and IL- 6 (90), Specificity found to be 88, 81, 97 and 94 respectively, PPV was 84, 74, 67 and 90 respectively, NPV was 100, 87, 62 and 94 respectively, accuracy was 92, 81, 62 and 92 respectively, AUC was 0.97, 0.81, 0.43 and 0.95 respectively. Conclusion: Authors found that CRP is the single best predictor of the severity of acute pancreatitis. IL-6 and PCT also are reliable predictors. PMN-Elastase needs to be assessed in patients with acute pancreatitis presenting early in the course of the illness.

Downloads

Download data is not yet available.

References

Yadav D, Ng B, Saul M, Kennard ED. Relationship of Serum Pancreatic Enzyme Testing Trends With the Diagnosis of Acute Pancreatitis. Pancreas. 2011;40(3):383–389. Available from: https://dx.doi.org/10.1097/mpa.0b013e3182062970.

Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. Classification of acute pancreatitis— 2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–111. Available from: https://dx.doi.org/10.1136/gutjnl-2012-302779.

Wu BU, Johannes RS, Sun X, Tabak Y, Conwell DL, Banks PA. The early prediction of mortality in acute pancreatitis: a large population-based study. Gut. 2008;57(12):1698–1703. Available from: https://dx.doi.org/10.1136/gut.2008.152702.

Uhl W, Isenmann R, Curti G, Vogel R, Beger HG, Buchler MW. Influence of Etiology on the Course and Outcome of Acute Pancreatitis. Pancreas. 1996;13(4):335–343. Available from: https://dx.doi.org/10.1097/00006676-199611000-00002.

Gullo L, Migliori M, Oláh A, Farkas G, Levy P, Arvanitakis C, et al. Acute Pancreatitis in Five European Countries: Etiology and Mortality. Pancreas. 2002;24(3):223–227. Available from: https://dx.doi.org/10.1097/00006676-200204000-00003.

Swaroop VS, Chari ST, Clain JE. Severe acute pancreatitis. JAMA. 2004;291:2865–2868.

Otsuki M, Takeda K, Matsuno S. Criteria for the diagnosis and severity stratification of acute pancreatitis. World J Gastroenterol. 2013;19(35):5798–5805. Available from: https://dx.doi.org/10.3748/wjg.v19.i35.5798.

Bereanu AS, Sava M. Correlation between Intra-Abdominal Pressure and C- Reactive Protein in Acute Pancreatitis. Acta Medica Transilvanica. 2015;20(4):109–113.

Liang Y, Zhao X, Meng F. Procalcitonin, C-reactive Protein, and Neutrophil Ratio Contribute to the Diagnosis and Prognosis of Severe Acute Pancreatitis. Iran J Public Health. 2020;48(12):2177–2177. Available from: https://dx.doi.org/10.18502/ijph.v48i12.3548.

Blamey SL, Imrie CW, O’Neill J, Gilmour WH, Carter DC. Prognostic factors in acute pancreatitis. Gut. 1984;25(12):1340–1346. Available from: https://dx.doi.org/10.1136/gut.25.12.1340. doi:10.1136/gut.25.12.1340.

Imrie CW, Benjamin IS, Ferguson JC, McKay AJ, Mackenzie I, O’Neill J, et al. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg. 1978;65(5):337–341. Available from: https://dx.doi.org/10.1002/bjs.1800650514.

Buxbaum J, Quezada M, Chong B, Gupta N, Yu CY, Lane C, et al. The Pancreatitis Activity Scoring System predicts clinical outcomes in acute pancreatitis: findings from a prospective cohort study. Am J Gastroenterol . 2018;113(5):755–764. Available from: https://dx.doi.org/10.1038/s41395-018-0048-1.

Published
2020-12-27